#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrosarcoma Waldenstrom's macroglobulinaemia Myeloid leukaemia Fallopian tube cancer Bronchiectasis Mixed-type liposarcoma Transitional cell cancer of the renal pelvis and ureter Iron overload Extranodal marginal zone B-cell lymphoma (MALT type) MELAS syndrome Mantle cell lymphoma stage IV Hepatitis D Severe myoclonic epilepsy of infancy Inclusion body myositis Arterial tortuosity syndrome More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease Waldenstrom’s macroglobulinaemia – Life with Disease Chronic granulomatous disease – Diagnostics Mucopolysaccharidosis I – Treatment Kearns-Sayre syndrome – Diagnostics Indolent systemic mastocytosis – Basic Information Glycogen storage disease type V – Trials in Disease Ewing’s sarcoma metastatic – Treatment Congenital nephrogenic diabetes insipidus – Life with Disease Angelman’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inclisiran Collagenase Farletuzumab Ecteribulin F125/10 68Ga-Dpi-4452 Selexipag Opelconazole OXYBUTYNIN HYDROCHLORIDE Bosutinib Mirabegron Contezolid Clofarabine Emedastine Sildenafil VG801-2 Dolutegravir Sodium Oric-114 Kk8123 GSK5458514 Bay 3018250 More therapies…

    Learn about Your Condition

    Krabbe's disease Vulvovaginal discomfort Pleural mesothelioma Mesothelioma Methylmalonic acidaemia Peripheral spondyloarthritis Haemoglobinuria Back pain Osteonecrosis of jaw Rectal cancer stage II Tubulointerstitial nephritis Endometrial stromal sarcoma Ovarian cancer Altered state of consciousness SAPHO syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prostate cancer

  • Study on the Safety and Effectiveness of 64Cu-DOTA-AE105 PET Imaging for Patients with Localized, Untreated Prostate Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 64Cu-Dota-Ae105
    Denmark Germany Sweden

  • Study on Bicalutamide and Drug Combination for Patients with Unfavorable Intermediate/High-Risk Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Bicalutamide
    Italy

  • Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Darolutamide
    France Spain

  • Study of High-Dose Radiation Therapy Combined with Goserelin for High-Risk Prostate Cancer Patients Using AI-Based Treatment Planning

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Goserelin
    Cyprus

  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to biliary tract
    • Metastases to central nervous system
    • Metastatic glioma
    Investigated Drugs:
    • 6-Fluoro-5-[4-[(5-Fluoro-2-Methyl-3-Oxo-4H-Quinoxalin-6-Yl)Methyl]Piperazin-1-Yl]-N-Methylpyridine-2-Carboxamide
    • [11C]Az14193391
    • Trastuzumab Deruxtecan
    Spain Sweden

  • Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Prostate Cancer After Radiation and Hormone Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Poland
Previous Page
1 2 3 4 5 6 … 17
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!